Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection.
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Scope of the Report:
This report focuses on the Methotrexate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.
Methotrexate is a drug used to treat several forms of cancer as well as some autoimmune system diseases. In 2014, methotrexate for breast, head and neck, lung, stomach, and esophagus cancers occupies more than 70% share of total amount. As the demand increases rapidly with higher spending propensity, the increased consumption is expected to continue during the remaining years of the forecast period of 2016-2021. Methotrexate industry will usher in a stable growth space.
The worldwide market for Methotrexate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Methotrexate for Injection
Methotrexate Tablets
Market Segment by Applications, can be divided into
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
There are 15 Chapters to deeply display the global Methotrexate market.
Chapter 1, to describe Methotrexate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Methotrexate, with sales, revenue, and price of Methotrexate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Methotrexate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Methotrexate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Methotrexate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis.
Scope of the Report:
This report focuses on the Methotrexate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The technical barriers of methotrexate are not high, and the methotrexate enterprise concentrate in China, USA, Australia, and the relative large companies include Teva Pharmaceutical Industries, Qualitestrx (DAVA Pharmaceuticals), Pfizer (Hospira), Roxane Laboratories, Sine, Maoxiang, LingNan Pharmaceutical and others.
Methotrexate is a drug used to treat several forms of cancer as well as some autoimmune system diseases. In 2014, methotrexate for breast, head and neck, lung, stomach, and esophagus cancers occupies more than 70% share of total amount. As the demand increases rapidly with higher spending propensity, the increased consumption is expected to continue during the remaining years of the forecast period of 2016-2021. Methotrexate industry will usher in a stable growth space.
The worldwide market for Methotrexate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries
Qualitestrx(DAVA Pharmaceuticals)
Pfizer (Hospira)
Roxane Laboratories
Sine
Maoxiang
LingNan Pharmaceutical
Powerdone
Huiyu
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Methotrexate for Injection
Methotrexate Tablets
Market Segment by Applications, can be divided into
Used for Cancers
Used for Rheumatoid Arthritis
Used for Other Diseases
There are 15 Chapters to deeply display the global Methotrexate market.
Chapter 1, to describe Methotrexate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Methotrexate, with sales, revenue, and price of Methotrexate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Methotrexate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Methotrexate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Methotrexate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
